Xenetic Biosciences Inc (XBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.89M
Last updated: Nov 17, 2026 at 8:24 AM ET
Xenetic Biosciences Inc (XBIO) Earnings: Report Dates and Results
Xenetic Biosciences (XBIO) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Xenetic Biosciences reported EPS of -$0.72. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
XBIO has an expected report date of Mar 10, 2027.
Earnings History
Of the 29 quarters below that had an estimate, XBIO beat 18, missed 10 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $725257, down 29.6% from $1.03M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.72 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2026 | $725257 |
| Jun 30, 2026 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 6, 2026 | $660601 |
| Mar 31, 2026 | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 12, 2026 | $806923 |
| Dec 31, 2025 | -$0.22 | -$0.52 | -$0.52 - -$0.52 | +57.69% | Beat | N/A | 1 | 1 up, 0 down | Mar 12, 2026 | $766296 |
| Sep 30, 2025 | -$0.33 | -$0.49 | -$0.49 - -$0.49 | +32.65% | Beat | N/A | 1 | 1 up, 0 down | Nov 12, 2025 | $1.03M |
| Jun 30, 2025 | -$0.45 | -$0.64 | -$0.64 - -$0.64 | +29.69% | Beat | N/A | 1 | 1 up, 0 down | Aug 12, 2025 | $589897 |
| Mar 31, 2025 | -$0.59 | -$0.72 | N/A | +18.06% | Beat | N/A | N/A | 0 up, 0 down | May 13, 2025 | $593261 |
| Dec 31, 2024 | -$0.68 | -$0.20 | N/A | -240.00% | Miss | N/A | N/A | 0 up, 0 down | Mar 18, 2025 | $648820 |
| Sep 30, 2024 | -$0.28 | -$0.14 | -$0.14 - -$0.14 | -100.00% | Miss | N/A | 1 | 0 up, 0 down | Nov 12, 2024 | $614243 |
| Jun 30, 2024 | -$0.83 | -$0.83 | -$0.83 - -$0.83 | 0.00% | In line | N/A | 1 | 0 up, 0 down | Aug 13, 2024 | $726404 |
| Mar 31, 2024 | -$0.78 | -$0.79 | -$0.79 - -$0.79 | +1.27% | Beat | N/A | 1 | 0 up, 0 down | May 9, 2024 | $510816 |
| Dec 31, 2023 | -$0.77 | -$0.87 | -$0.87 - -$0.87 | +11.49% | Beat | N/A | 1 | 0 up, 0 down | Mar 21, 2024 | $671963 |
| Sep 30, 2023 | -$0.69 | -$1.12 | N/A | +38.39% | Beat | N/A | N/A | 0 up, 0 down | Nov 10, 2023 | $611174 |
| Jun 30, 2023 | -$0.69 | -$1.13 | -$1.13 - -$1.13 | +38.94% | Beat | N/A | 1 | 0 up, 0 down | Aug 11, 2023 | $651005 |
| Mar 31, 2023 | -$0.60 | -$1.10 | -$1.10 - -$1.10 | +45.45% | Beat | N/A | 1 | 0 up, 0 down | May 11, 2023 | $605844 |
| Dec 31, 2022 | -$0.10 | -$0.09 | -$0.09 - -$0.09 | -11.11% | Miss | N/A | 1 | 0 up, 0 down | Mar 23, 2023 | $486972 |
| Sep 30, 2022 | -$0.60 | -$1.80 | -$1.80 - -$1.80 | +66.67% | Beat | N/A | 1 | 0 up, 0 down | Nov 10, 2022 | $414250 |
| Jun 30, 2022 | -$1.90 | -$1.20 | N/A | -58.33% | Miss | N/A | N/A | 0 up, 0 down | Aug 12, 2022 | $416710 |
| Mar 31, 2022 | -$1.20 | -$1.10 | -$1.10 - -$1.10 | -9.09% | Miss | N/A | 1 | 0 up, 0 down | May 12, 2022 | $388993 |
| Dec 31, 2021 | -$0.14 | -$0.15 | N/A | +6.67% | Beat | N/A | N/A | 0 up, 0 down | Mar 22, 2022 | $332604 |
| Sep 30, 2021 | -$1.30 | -$1.20 | -$1.20 - -$1.20 | -8.33% | Miss | N/A | 1 | 1 up, 0 down | Nov 12, 2021 | $349269 |
| Jun 30, 2021 | -$1.30 | -$1.60 | -$1.60 - -$1.60 | +18.75% | Beat | N/A | 1 | N/A | Aug 12, 2021 | $287603 |
| Mar 31, 2021 | -$1.50 | -$1.30 | -$1.30 - -$1.30 | -15.38% | Miss | N/A | 1 | N/A | May 12, 2021 | $191216 |
| Dec 31, 2020 | -$0.16 | -$0.20 | -$0.25 - -$0.15 | +20.00% | Beat | N/A | 2 | N/A | Mar 16, 2021 | $151332 |
| Sep 30, 2020 | -$1.42 | -$1.30 | -$1.80 - -$1.30 | -9.23% | Miss | N/A | 2 | N/A | Nov 12, 2020 | $115934 |
| Jun 30, 2020 | -$1.50 | -$2.20 | -$2.20 - -$2.20 | +31.82% | Beat | N/A | 1 | N/A | Aug 12, 2020 | $112927 |
| Mar 31, 2020 | -$1.90 | -$3.70 | N/A | +48.65% | Beat | N/A | N/A | N/A | May 14, 2020 | $56749 |
| Dec 31, 2019 | -$0.20 | -$0.38 | N/A | +47.37% | Beat | N/A | N/A | N/A | Mar 26, 2020 | $17066 |
| Sep 30, 2019 | -$2.67 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 15, 2019 | N/A |
| Jun 30, 2019 | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 15, 2019 | N/A |
| Mar 31, 2019 | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 10, 2019 | N/A |
| Dec 31, 2018 | -$2.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2019 | N/A |
| Sep 30, 2018 | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 9, 2018 | N/A |
| Jun 30, 2018 | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 10, 2018 | N/A |
| Mar 31, 2018 | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2018 | $7.50M |
| Dec 31, 2017 | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2018 | $7.50M |
| Sep 30, 2017 | -$31.20 | -$49.20 | N/A | +36.59% | Beat | N/A | N/A | N/A | Nov 15, 2017 | $85000 |
| Jun 30, 2017 | -$40.80 | -$46.80 | N/A | +12.82% | Beat | N/A | N/A | N/A | Aug 14, 2017 | N/A |
| Mar 31, 2017 | -$40.80 | -$25.20 | N/A | -61.90% | Miss | N/A | N/A | N/A | Apr 3, 2017 | N/A |
| Dec 31, 2016 | -$6.84 | -$2.28 | N/A | -200.00% | Miss | N/A | N/A | N/A | Mar 31, 2017 | $3.00M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.59, after -$2.57 the year before. It was -$838.22 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.59 | N/A |
| Dec 31, 2024 | -$2.57 | N/A |
| Dec 31, 2023 | -$2.75 | N/A |
| Dec 31, 2022 | -$3.80 | N/A |
| Dec 31, 2021 | -$4.24 | N/A |
| Dec 31, 2020 | -$4.98 | N/A |
| Dec 31, 2019 | -$3.39 | N/A |
| Dec 31, 2018 | -$2.87 | N/A |
| Dec 31, 2017 | -$113.06 | N/A |
| Dec 31, 2016 | -$838.22 | N/A |
Frequently Asked Questions About XBIO
When is Xenetic Biosciences's next earnings date?
Xenetic Biosciences's next earnings report is expected for Mar 10, 2027.
How often does XBIO beat earnings estimates?
Xenetic Biosciences beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of -25.08%.
XBIO pages: Overview, Earnings, Forecast, Financials, Competitors